| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.47B | +51.6% |
| R&D Expense | $355.0M | +9.9% |
| SG&A Expense | $628.0M | +38.0% |
| Pre-tax Income | $2.11B | +98.1% |
| Income Tax | $225.0M | +164.8% |
| Net Income | $1.88B | +33.5% |
| EPS (Basic) | $2.12 | +32.5% |
| EPS (Diluted) | $2.05 | +31.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.26B | -1.6% |
| Current Assets | $36.30B | +44.6% |
| Total Assets | $38.14B | +45.6% |
| Current Liabilities | $28.77B | +58.9% |
| Total Liabilities | $28.99B | +59.1% |
| Stockholders' Equity | $9.15B | +14.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.64B | +1143.3% |
| Investing Cash Flow | $141.0M | +195.3% |
| Financing Cash Flow | -$590.0M | -71.0% |